|Bid||0.00 x 800|
|Ask||0.00 x 1400|
|Day's Range||57.55 - 59.40|
|52 Week Range||33.93 - 59.40|
|Beta (3Y Monthly)||0.71|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 5, 2019 - Aug 9, 2019|
|Forward Dividend & Yield||0.35 (0.59%)|
|1y Target Est||58.85|
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Dentsply Sirona Inc. New York, June 24, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Dentsply Sirona Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
Does Dentsply International (XRAY) have what it takes to be a top stock pick for momentum investors? Let's find out.
DENTSPLY SIRONA Inc NASDAQ/NGS:XRAYView full report here! Summary * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for XRAY with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting XRAY. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold XRAY had net inflows of $1.57 billion over the last one-month. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
"The global economic environment is very favorable for investors. Economies are generally strong, but not too strong. Employment levels are among the strongest for many decades. Interest rates are paused at very low levels, and the risk of significant increases in the medium term seems low. Financing for transactions is freely available to good borrowers, […]
Baxter (BAX) expects its bottom line to rise in the second quarter of 2019, courtesy to Renal Care and Clinical Nutrition businesses.
Because of a growing demand for aligners used to straighten teeth, a company with a growing DFW presence is looking to add hundreds of employees in the next few years.
Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Passive investing in index funds can generate returns that roughly match the overall market. But you can significantly...
President & CEO of Dentsply Sirona Inc (NASDAQ:XRAY) Donald M Jr. Casey bought 10,000 shares of XRAY on 05/29/2019 at an average price of $53.68 a share.